Intradiscal Glucocorticoid Injection in Discogenic Back Pain and Influence on Modic Changes: A Systematic Review and Meta-analysis of RCTs.

Riegger, Martin; Le, Huyen; van Kuijk, Sander M J; Guyenes, Gabor; Candrian, Christian; Cianfoni, Alessandro; Hirsch, Joshua A; Koetsier, Eva (2023). Intradiscal Glucocorticoid Injection in Discogenic Back Pain and Influence on Modic Changes: A Systematic Review and Meta-analysis of RCTs. Pain physician, 26(5), E449-E465. American Society of Interventional Pain Physicians

Text 2023_26_E449-E465.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (630kB) | Request a copy

BACKGROUND

The benefit of intradiscal glucocorticoid injection (IGI) for discogenic low back pain (LBP) remains controversial.

OBJECTIVES

The objective of this study was to systematically assess and meta-analyze the efficacy of IGI compared with these control groups.

STUDY DESIGN

Systematic review and meta-analysis.

METHODS

A comprehensive literature search was performed screening PubMed and Embase through May 2022. Only randomized controlled trials (RCTs) comparing IGI to control groups in adult patients with discogenic lumbar back pain were included. A random effects model was used to pool mean differences of pain intensity (visual analaog scale [VAS] 0-100), and physical function assessed with the Oswestry Disability Index (ODI). Subgroup analyses were stratified by Modic magnetic resonance imaging findings.

RESULTS

Seven studies met inclusion criteria with a total of 626 patients. The short-term (< 3 months) follow-up showed a significant pooled mean difference in both pain intensity (-20.1; 95% CI, -25.5 to -14.7) and physical function (-9.9; 95% CI, -16.1 to -3.6). In the intermediate -term follow-up (3 to < 6 months), only physical function remained significantly better in the glucocorticoid group (-13.1; 95% CI, -22.3 to -3.9). There was no clinically meaningful or significant difference in pain scores and physical function at the long-term (>= 6 months) follow-up. A subgroup analysis did not demonstrate an effect of Modic (type I) changes on the efficacy of IGI.

LIMITATIONS

A limited number of studies was available and consequently publication bias could not be evaluated using a funnel plot. Statistical heterogeneity was detected among the included studies.

CONCLUSION

We conclude that IGI reduces discogenic LBP intensity and improves physical function effectively at short-term follow-up, and continues to improve physical function at intermediate-term. However, 6 months posttreatment, outcomes are similar in comparison to the control groups. The type of Modic change does not appear to be related with the response to IGI.

KEY WORDS

Low back pain, lumbar back pain, intradiscal glucocorticoid injection, modic changes, meta-analysis.

Interest & Impact

Downloads

0 since deposited on 03 Oct 2023
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item